Predicted protein targets (top 12)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CAPN1 | P07384 | 1/20 | 0.37 |
| ▸ | GLO1 | Q04760 | 1/20 | 0.35 |
| ▸ | NOD1 | Q9Y239 | 1/20 | 0.34 |
| ▸ | BCHE | P06276 | 1/20 | 0.34 |
| ▸ | ACHE | P22303 | 1/20 | 0.34 |
| ▸ | CTSS | P25774 | 2/20 | 0.34 |
| ▸ | CTSK | P43235 | 2/20 | 0.34 |
| ▸ | PLK1 | P53350 | 2/20 | 0.32 |
| ▸ | CCKBR | P32239 | 1/20 | 0.32 |
| ▸ | GLP1R | P43220 | 7/20 | 0.32 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.31 |
| ▸ | P2RY12 | Q9H244 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL22373639 | 0.95 | CAPN1 (0.38) | CAPN1GLO1NOD1BCHEACHE | |
| SCHEMBL20998090 | 0.89 | CAPN1 (0.33) | CAPN1GLO1NOD1BCHEACHE | |
| SCHEMBL19505993 | 0.88 | CAPN1 (0.33) | CAPN1GLO1NOD1BCHEACHE | |
| SCHEMBL19506154 | 0.81 | CTSS (0.37) | CAPN1GLO1NOD1CTSSCTSK | |
| SCHEMBL30019872 | 0.81 | NOD1 (0.47) | CAPN1NOD1GLP1R | |
| SCHEMBL20998108 | 0.81 | CTSK (0.41) | CAPN1GLO1NOD1CTSSCTSK | |
| SCHEMBL30019912 | 0.80 | NOD1 (0.47) | CAPN1NOD1GLP1R | |
| SCHEMBL24235778 | 0.79 | GLP1R (0.43) | CAPN1NOD1GLP1R | |
| SCHEMBL24235602 | 0.76 | GLO1 (0.42) | CAPN1GLO1NOD1CTSSCTSK | |
| SCHEMBL30020812 | 0.75 | GLP1R (0.46) | CAPN1NOD1GLP1R |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20170290925-A1 | Conjugates And Conjugating Reagents | POLYTHERICS LIMITED (GB) | 2017-10-12 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20170290925-A1 | Conjugates And Conjugating Reagents | ANPEP, NGLY1, PCTP | CAPN1 2310/4885GLO1 1668/4885NOD1 4282/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.